Uploaded April 2026 | Updated September 2026, 2 weeks ago
Eric Appel, PhD
Associate Professor of Materials Science and Engineering
Lee Otterson Faculty Scholar
Many of today’s most precise medicines are protein-based, which leaves them particularly fragile. Proteins tend to clump together, making these drugs unstable and difficult to store, ship, and deliver. This challenge has limited the development of these promising therapies due to a shortage of stabilizing ingredients and formulation strategies. In this keynote, you’ll hear how Dr. Appel’s lab at Stanford Engineering has made advancements in developing novel stabilizers and formulation approaches that maintain the stability and effectiveness of these protein drugs, addressing crucial challenges to enhance their safety, efficacy, and accessibility for patients worldwide.
Eric Appel, PhD
Associate Professor of Materials Science and Engineering
Lee Otterson Faculty Scholar
Many of today’s most precise medicines are protein-based, which leaves them particularly fragile. Proteins tend to clump together, making these drugs unstable and difficult to store, ship, and deliver. This challenge has limited the development of these promising therapies due to a shortage of stabilizing ingredients and formulation strategies. In this keynote, you’ll hear how Dr. Appel’s lab at Stanford Engineering has made advancements in developing novel stabilizers and formulation approaches that maintain the stability and effectiveness of these protein drugs, addressing crucial challenges to enhance their safety, efficacy, and accessibility for patients worldwide.
